Ancora Advisors LLC Invests $2.39 Million in The Cooper Companies, Inc. $COO

Key Points

• Ancora Advisors initiated a $2.39 million position in Cooper Companies during the second quarter by purchasing 33,390 shares. Several other institutional investors also established new stakes, with institutions and hedge funds now owning 24.39% of the stock.
• Cooper Companies exceeded quarterly expectations, reporting $1.21 in earnings per share versus the $1.10 consensus estimate and $1.08 billion in revenue. Revenue increased 7.9% year over year, while fiscal 2026 guidance calls for $4.58–$4.66 in EPS.
• Analyst sentiment is mixed: the stock has an average “Hold” rating and a consensus price target of $81.64, compared with a recent price of $72.68. Price targets range from $66 to $86 among recently updated ratings.

Ancora Advisors LLC bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 33,390 shares of the medical device company's stock, valued at approximately $2,394,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Expect Equity LLC acquired a new position in Cooper Companies during the 2nd quarter worth approximately $3,015,000. Legal & General Group Plc purchased a new position in shares of Cooper Companies during the 2nd quarter worth approximately $60,521,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at approximately $69,129,000. Sone Capital Management LLC acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at approximately $27,754,000. Finally, Trajan Wealth LLC purchased a new stake in shares of Cooper Companies in the second quarter valued at approximately $19,348,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $72.68 on Thursday. The business's fifty day moving average price is $72.36 and its two-hundred day moving average price is $70.96. The stock has a market cap of $14.17 billion, a PE ratio of 61.59, a price-to-earnings-growth ratio of 1.91 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies's revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on COO. Piper Sandler set a $86.00 price objective on Cooper Companies and gave the stock an "overweight" rating in a report on Monday, June 1st. Wells Fargo & Company reissued a "sell" rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Wall Street Zen upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating in a research report on Sunday, June 21st. Needham & Company LLC lowered their price target on shares of Cooper Companies from $101.00 to $86.00 and set a "buy" rating on the stock in a research note on Friday, June 5th. Finally, KeyCorp reiterated a "sector weight" rating on shares of Cooper Companies in a report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $81.64.

Cooper Companies Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source